Patient ServicesMedicinal cannabis assessment, physician appointments and nursing support
Services for Tetra Health Patients
Medical cannabis is not like other prescription medications. Pathways to access are complex, and treatment response is highly individual due to a number of factors.
Currently in Australia, patients are only eligible for medicinal cannabis if they have a diagnosed chronic condition and they have trialled conventional pharmaceutical drugs and have experienced adverse effects, or their symptoms are not fully controlled.
At this time, Medicinal Cannabis is not a first line therapy.
We assist patients in making informed choices and offer guidance based on clinical research and real patient data. If deemed suitable for treatment by your doctor or our nursing team, you can expect personalised treatment plans, ongoing support from our specialist nurses, a 1800 support line and a review of cannabinoid medicines that best suit your symptoms.
Tetra has access to a number of different medications that vary in cannabinoid content. Tetra is product agnostic and our doctors only prescribe TGO 93 approved medical cannabis products which are regulated by the Therapeutic Goods Administration (TGA) in Australia.
Become a Patient at Tetra Health
Our team of specialist physicians accept patient referrals for a wide range of conditions. You can find out more about these below. At Tetra Health, we require a Referral or Health Summary to be assessed by our team.
Your GP or specialist can refer you for assessment by emailing or faxing our Referral Form, or by using our E-Referral Option
Our Physician Information Pack can be taken to your doctor which explains Tetra Health, our process, and how your doctor can refer you quickly and simply. If your doctor has questions – they can contact our medical team directly through [email protected] or 1800 861 099.
If you’re having trouble getting a Referral, you can alternatively call the clinic reception at your doctor’s office and ask that a Health Summary be faxed to Tetra Health at +61280790656.
What is Medicinal Cannabis?
The cannabis plant has been utilised for its medicinal properties for centuries. It produces more than 700 active ingredients, and over 100 of those are cannabinoids. Cannabinoids are a diverse group of compounds which act via humans’ own cannabis pathways called the endocannabinoid system (ECS). The ECS is responsible for regulating appetite, sleep, metabolism, modulation of pain, muscle function and the immune system. You can read more about the Endocannabinoid System here.
The most widely studied cannabinoids are THC and CBD. THC and CBD interact with the body’s Endocannabinoid System. Clinical evidence has shown that THC may be effective for:
- nausea and vomiting1-5
- chronic pain6-14
- sleep disorders11, 15, 16
- and more
Clinical evidence has shown that CBD may be effective for
chronic pain1, 37, 38
autism spectrum disorder43-47
The different combinations of these compounds in cannabis medications have a wide range of effects on our individual endocannabinoid systems. Read more about THC and CBD here. References for the above can be found here.
The TGA has also published medicinal cannabis guidance documents which can be found here.
Why Choose Tetra Health
At Tetra, we are product agnostic and our doctors prescribe a wide range of medications. Every patient is unique, so that means we find the best medication for you.
As a leader in patient care, we offer 5-star support. Tetra believes in full transparency and have no hidden fees. You can read about patient experiences here.
We obtain TGA approvals within 24-48 hours after your physician consult. Our phone / video consults are done from the comfort of your home – a quick and pain-free process.
When you choose Tetra, you choose ongoing support and expertise. Our medical team is beside you every step of the way, ensuring you get the most out of your medication.
TGA Approved Indications
Medicinal cannabis may be helpful with the management of symptoms associated with a wide variety of conditions that have not responded to conventional treatments. The TGA does not have an approved list of indications that may be applied for.
The TGA has approved a wide range theraputic areas under the Special Access Scheme which have been published on the TGA Website under the Freedom of Information Disclosure log which have been extrapolated and detailed below:
- Cancer-Related Pain
- Chronic Pain
- Chronic Regional Pain Syndrome (CRPS)
- Ehlers Danlos Syndromes (EDS)
- Musculoskeletal Pain
- Cluster Headache
- Neuropathic Pain
- Palliative Care
- Aggressive Behaviour
- Autism Spectrum Disorder (ASD)
- Alzheimer’s Disease
- Epilepsy – Adult/Child
- Essential Tremor
- Movement disorder
- Multiple sclerosis (MS)
- Parkinson’s Disease
- Restless leg syndrome
- Tourette’s Syndrome
- Bi-Polar Disorder
- Mood Disorder
- Obsessive-Compulsive Disorder (OCD)
- Post Traumatic Stress Disorder (PTSD)
- Anxiety / Sleep Issues
- Chemotherapy induced nausea and vomiting (CINV)
- Cancer-Related Appetite Loss
- Cancer-Related Pain
- Palliative care
- Crohn’s Disease
- Ulcerative Colitis
- Irritable Bowel Syndrome (IBS)
- Inflammatory Bowel Disease (IBD)
Join the Tetra community to advance your knowledge in cannabinoid medicines and gain access to our global network of medical specialists that can support your clinical decisions to prescribe medical cannabis for your patients.